Call for Submissions
January 26, 2024
Blog The John Grube Foundation e.V., based in Hamburg, awards the “John Grube Prize” in honour of its namesake, who died young of granulomatosis with
Blog The John Grube Foundation e.V., based in Hamburg, awards the “John Grube Prize” in honour of its namesake, who died young of granulomatosis with
Blog TAVNEOS® (avacopan), a First-in-Class Medicine for Patients With Severe Active ANCA-Associated Vasculitis, Added to Inflammation Portfolio THOUSAND OAKS, Calif., (Oct. 20, 2022) – Amgen (NASDAQ: AMGN)
Blog The US Food and Drug Administration (FDA) has granted approval for Regeneron Pharmaceuticals and Sanofi’s Kevzara (sarilumab) to treat polymyalgia rheumatica (PMR) in adult
Blog First head-to-head trial of biologics in EGPA, comparing a single monthly injection of Fasenra to three injections per month of mepolizumab Positive high-level results
Blog 6-Month Check-In FormsVPPRN Community Dashboard | January 2023Take a look below at what we learned from the VPPRN community about FATIGUE, PAIN, FLARES and
Blog Update: Jo has made it to the top of Mt. Kilimanjaro! The climb was by far the hardest thing she’s ever had to face
Blog Announcing the 2022 Patient Heroes Ordinary people can become extraordinary in their journey through life — and this has never been truer than it
Blog There’s something unique about the Vasculitis Foundation’s (VF’s) 2022 Recognizing Excellence in Diagnostics (V-RED) award program: We have two winners who tied for first
Blog Nona is a nationally known advocate of healthcare reform and champion of seniors’ issues. Originally an academic who served on the faculties of several
Blog Vasculitis and ANCA Workshop | April 2022 | Dublin, Ireland As part of the 20th International Vasculitis and ANCA Workshop, our investigators examined changes